Increased monocytic CD14+HLADRlow/- myeloid-derived suppressor cells in obesity

Bao,Yi; Mo,Juanfen; Ruan,Lingjuan; Li,Guo

doi:10.3892/mmr.2014.2927

Increased monocytic CD14+HLADRlow/- myeloid-derived suppressor cells in obesity

Authors:
- Yi Bao
- Juanfen Mo
- Lingjuan Ruan
- Guo Li
View Affiliations

Affiliations: Department of Basic and Translational Research, The Key Laboratory, The Second Hospital of Jiaxing, Jiaxing, Zhejiang 314000, P.R. China
Published online on: November 11, 2014 https://doi.org/10.3892/mmr.2014.2927
Pages: 2322-2328

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Obesity is associated with numerous immunological disorders. The present study investigated the proportion and phenotype of myeloid‑derived suppressor cells (MDSCs) in the plasma of obese subjects and the association of these cells with the level of liver enzymes. Certain features of the immune response in obese subjects were examined by analyzing the expression of T cell receptor‑ζ (TCRζ) molecules on the surface of T cells. The expression and secretion of S100A9, a possible marker for MDSCs, were detected in the peripheral blood of obese subjects and compared with levels in lean controls. Results showed that the percentage of monocytic MDSCs, with the phenotype CD33+CD11b+CD14+HLADRlow/‑, was significantly increased in obese subjects compared with lean controls. The circulating level of monocytic MDSCs was positively correlated with the levels of liver enzymes in serum. The expression of the TCRζ molecule in the resting T cells was significantly lower in obese individuals than that of lean controls. The expression of S100A9 was detected in the majority of monocytes in peripheral blood mononulear cells, but no difference was identified in the frequency of CD14+S100A9+ cells between the obese and lean groups. However, the plasma level of S100A8/9 was significantly increased in obese compared with lean subjects. These observations suggested that the increased frequency of CD33+CD11b+CD14+HLADRlow/‑ cells may be responsible for the impaired T‑cell function and liver injury observed in obesity.

View Figures

View References

1	Renehan AG, Tyson M, Egger M, Heller RF and Zwahlen M: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 371:569–578. 2008. View Article : Google Scholar : PubMed/NCBI
2	Rader DJ: Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med. 120(Suppl 1): S12–S18. 2007. View Article : Google Scholar : PubMed/NCBI
3	de Leal VO and Mafra D: Adipokines in obesity. Clin Chim Acta. 419:87–94. 2013. View Article : Google Scholar
4	van der Weerd K, Dik WA, Schrijver B, et al: Morbidly obese human subjects have increased peripheral blood CD4⁺ T cells with skewing toward a Treg- and Th2-dominated phenotype. Diabetes. 61:401–408. 2012. View Article : Google Scholar : PubMed/NCBI
5	de Heredia FP, Gómez-Martinez S and Marcos A: Obesity, inflammation and the immune system. Proc Nutr Soc. 71:332–338. 2012. View Article : Google Scholar : PubMed/NCBI
6	Wagner NM, Brandhorst G, Czepluch F, et al: Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring). 21:461–468. 2013. View Article : Google Scholar
7	Lindau D, Gielen P, Kroesen M, Wesseling P and Adema GJ: The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology. 138:105–115. 2013. View Article : Google Scholar :
8	Umansky V and Sevko A: Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation. Cancer Immunol Immunother. 61:275–282. 2012. View Article : Google Scholar
9	Irving BA, Chan AC and Weiss A: Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J Exp Med. 177:1093–1103. 1993. View Article : Google Scholar : PubMed/NCBI
10	Irving BA and Weiss A: The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell. 64:891–901. 1991. View Article : Google Scholar : PubMed/NCBI
11	Srivastava MK, Andersson Å, Zhu L, et al: Myeloid suppressor cells and immune modulation in lung cancer. Immunotherapy. 4:291–304. 2012. View Article : Google Scholar : PubMed/NCBI
12	Zhao F, Hoechst B, Duffy A, et al: S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology. 136:176–183. 2012. View Article : Google Scholar : PubMed/NCBI
13	Schouppe E, Van Overmeire E, Laoui D, et al: Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells. Immunobiology. 218:1385–1391. 2013. View Article : Google Scholar : PubMed/NCBI
14	Kono K, Ressing ME, Brandt RM, et al: Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res. 2:1825–1828. 1996.PubMed/NCBI
15	Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of nonalcoholic fatty liver disease. Zhoonghua Gan Zang Bing Za Zhi. 11:712003.(In Chinese).
16	Kusmartsev S, Su Z, Heiser A, et al: Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res. 14:8270–8278. 2008. View Article : Google Scholar : PubMed/NCBI
17	Ozao-Choy J, Ma G, Kao J, et al: The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 69:2514–2522. 2009. View Article : Google Scholar : PubMed/NCBI
18	Wang L, Chang EW, Wong SC, et al: Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol. 190:794–804. 2013. View Article : Google Scholar
19	Filipazzi P, Valenti R, Huber V, et al: Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol. 25:2546–2553. 2007. View Article : Google Scholar : PubMed/NCBI
20	Gebhardt C, Németh J, Angel P and Hess J: S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 72:1622–1631. 2006. View Article : Google Scholar : PubMed/NCBI
21	Foell D, Wittkowski H, Ren Z, et al: Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol. 216:183–192. 2008. View Article : Google Scholar : PubMed/NCBI
22	Auffray C, Sieweke MH and Geissmann F: Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 27:669–692. 2009. View Article : Google Scholar : PubMed/NCBI
23	Hansmann L, Groeger S, von Wulffen W, Bein G and Hackstein H: Human monocytes represent a competitive source of interferon-alpha in peripheral blood. Clin Immunol. 127:252–264. 2008. View Article : Google Scholar : PubMed/NCBI
24	Lin Y, Gustafson MP, Bulur PA, et al: Immunosuppressive CD14+HLA-DR(low)/− monocytes in B-cell non-Hodgkin lymphoma. Blood. 117:872–881. 2011. View Article : Google Scholar :
25	Najjar YG and Finke JH: Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Front Oncol. 3:492013. View Article : Google Scholar : PubMed/NCBI
26	Monneret G, Lepape A, Voirin N, et al: Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 32:1175–1183. 2006. View Article : Google Scholar : PubMed/NCBI
27	Mentula P, Kylänpää-Bäck ML, Kemppainen E, et al: Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Sci (Lond). 105:409–417. 2003. View Article : Google Scholar
28	Antoniades CG, Berry PA, Davies ET, et al: Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology. 44:34–43. 2006. View Article : Google Scholar : PubMed/NCBI
29	Zimmermann HW, Trautwein C and Tacke F: Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol. 3:562012. View Article : Google Scholar : PubMed/NCBI
30	Trayhurn P and Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 92:347–355. 2004. View Article : Google Scholar : PubMed/NCBI
31	Trayhurn P, Bing C and Wood IS: Adipose tissue and adipokines - energy regulation from the human perspective. J Nutr. 136(Suppl 7): 1935S–1939S. 2006.
32	Rahimi RS and Landaverde C: Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment. Nutr Clin Pract. 28:40–51. 2013. View Article : Google Scholar : PubMed/NCBI
33	Höchst B, Schildberg FA, Sauerborn P, et al: Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J Hepatol. 59:528–535. 2013. View Article : Google Scholar : PubMed/NCBI
34	Baniyash M: TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol. 4:675–687. 2004. View Article : Google Scholar : PubMed/NCBI
35	Whiteside TL: Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer? Cancer Immunol Immunother. 53:865–878. 2004.PubMed/NCBI
36	Sinha P, Okoro C, Foell D, et al: Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol. 181:4666–4675. 2008. View Article : Google Scholar : PubMed/NCBI